Abstract
Subject retention is one of the key factors that determine success of a clinical trial. Many researchers have focused on the issue of recruitment, and few have focused on retention. Subjects discontinue from clinical trials for variety of reasons. Sociodemographic characteristics such as age, gender, race, employment, and level of education have been implicated as the most common influencers for participation in clinical trials. This study evaluated the influence of these sociodemographic characteristics on the risk of subject discontinuation. There was little apparent difference in the sociodemographic characteristics among completers and discontinued subjects. Importantly, it was noticed that there is no common format for reporting clinical trial sociodemographic characteristics, thus leading to difficulties in the interpretation of the influence of such factors on subject retention. Suggestions are provided for future researchers that would greatly enhance the prediction of sociodemographic influences on subject discontinuation. Strategies to overcome such influences may be required.
Similar content being viewed by others
References
Heskett K. Clinical trials: issues and resources. J Consumer Health Internet. 2004;8(3):35–52.
Sullivan J. Subject recruitment and retention: barriers to success. 2004. https://doi.org/www.appliedclinicaltrialsonline.com/appliedclinicaltrials/article/articleDetail.jsp?id=89608.
Connor SH. An integrated approach for clinical trial patient retention. 2010. https://doi.org/www.ngpharmasummit.com/media/whitepapers/Acurian_Retention_NGPUS.pdf.
Elvidge S. The importance of patient retention strategies. Life Sci Leader. 2010. https://doi.org/www.lifescienceleader.com/magazine/past-issues3/item/3460-the-importance-of-patient-retention-strategies?list=n.
Kittredge C. A shrinking target: clinical trials are taking longer, and costing more, as competition for patients’ heat up. Scientist-Philadelphia. 2005;19(7):46–49.
Kaitin K, ed. Growing protocol design complexity stresses investigators, volunteers. Tufts CSDD Impact Rep. 2008;10(1):1–4.
Getz K. Public confidence and trust today. Monitor 2008;(Sept): 8–21.
Davis M, Addis M. Predictors of attrition from behavioral medicine treatments. Ann Behav Med. 1999;21:339–349.
Frederick LG. Participant retention in clinical research: a major challenge. 2011. https://doi.org/www.healthsystem.virginia.edu/internet/ican/lgf_spring_08.doc.
Good M, Schuler L. Subject retention in a controlled clinical trial. J Adv Nurs. 1997;26:351–355.
Mor M, Niv G, Niv Y. Patient retention in a clinical trial: a lesson from the rofecoxib (VIOXX) study. Dig Dis Sci. 2006;51(7):1175–1178.
Betz D, Betz D, Leahy D. Burden of patient dropouts and patients lost-to-follow-up on clinical studies. 2009. https://doi.org/www.lost-to-follow-up.com/faqs#q8.
Hellard ME, Sinclair MI, Forbes AB, Fairley CK. Methods used to maintain a high level of participant involvement in a clinical trial. J Epidemiol Com Health. 2001;55:348–351.
Kerr DJ, Knox K, Robertson DC, Stewart D, Watson R. Questions about clinical trials: a framework for discussion. In: Kerr DJ, Knox K, Robertson DC, Stewart D, Watson R, eds. Clinical Trials Explained: A Guide to Clinical Trials in the NHS for Healthcare Professionals. Cambridge, MA: Blackwell; 2006:38–45.
Morse EV, Simon PM, Besch CL, Walker J. Issues of recruitment, retention and compliance in community based clinical trials with traditionally underserved populations. Appl Nurs Res. 1995;8:8–14.
Demi AS, Warren NA. Issues in conducting research with vulnerable families. West J Nurs Res. 1995;17:188–202.
Given BA, Keilman LJ, Collins C, Given CW. Strategies to minimize attrition in longitudinal studies. Nurs Res. 1990;39:184–186.
Wineman NM, Durand E. Incentives and rewards for subjects in nursing research. West J Nurs Res. 1992;14:526–531.
Rudy EB, Estok PJ, Kerr ME, Menzel L. Research incentives: Money versus gifts. Nurs Res. 1994;43:253–255.
Robinson S, Marsland L. Approaches to the problem of respondent attrition in a longitudinal panel study of nurses’ careers. J Adv Nurs. 1994;20:729–741.
Beck CT. Subject mortality: is it inevitable? West J Nurs Res. 1984;6:331–339.
Martin KM. Coordinating multidisciplinary collaborative research: a formula for success. Clin Nurs Specialist. 1994;8(1):18–22.
Glasgow R, Nelson C, Kearney K et al. Reach, engagement and retention in an internet based weight loss program in a multisite randomized controlled trial. J Med Internet Res. 2007;9(e):11.
Honas J, Early J, Frederickson D, O’Brien M. Predictors of attrition in a large clinic based weight-loss program. Obes Res. 2003;11:888–894.
Janson S, Alioto M, Boushy H. Attrition and retention of ethnically diverse subjects in a multicenter randomized controlled research trial. Control Clin Trials. 2001;22:236S–43S.
El-Khorazaty MN, Johnson A, Kiely M et al. Recruitment and retention of low-income minority women in a behavioral intervention to reduce smoking, depression, and intimate partner violence during pregnancy. BMC Public Health. 2007;7:233.
Moser DK, Dracup K, Doering LV. Factors differentiating dropouts from completers in a longitudinal, multicenter clinical trial. Nurs Res. 2000;49(2):109–116.
Kennedy B, Paeratakul S, Champane C, et al. A pilot church—based weight loss program for African American adults utilizing church members as health educators: a comparison of individual and group intervention. Ethnicity Dis. 2005;15:373–378.
Lopez-Goni JJ, Fernandez-Montalvo J, III Escas C, Landa N, Lorea I. Determining socio-demographic predictors of treatment dropout: results in a therapeutic community. Int J Soc Welfare. 2008;17:374–378.
Larson EL, Ferng Y, McLoughlin J, Wang S. Retention and protocol adherence of Hispanic volunteers in a longitudinal trial. Am J Health Behav. 2009;33(4):435–444.
Bender BG, Ikle DN, DuHamel T, Tinkelman D. Retention of asthmatic patients in a longitudinal clinical trial. J Allergy Clin Immunol. 1977;99(2):197–203.
Sonawalla SB, Farabaugh AH, Leslie VM, Pava JA, Matthews JD, Fava M. Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:415–419.
Cramer JA, Collins JF, Mattson RH. Can categorization of patient background problems be used to determine early termination in a clinical trial? Control Clin Trials. 1988;9:47–63.
Busnello RG, Melchior R, Faccin C et al. Characteristics associated with the dropout of hypertensive patients followed up in an outpatient referral clinic. Arq Bras Cardiol. 2001;76(5):352–354.
Mattson P, Tomson T, Eriksson O. Socio-demographic differences in antiepileptic drug prescriptions to adult epilepsy patients. Am Acad Neurol. 2010;74:295–301.
King AC, Canada SA. Client-related predictors of early treatment drop-out in a substance abuse clinic exclusively employing individual therapy. J Subst Abuse Treatment. 2004;26:189–195.
Doody R, Pavlik V, Massman P, et al. Changing patient characteristics and survival experience in an Alzheimer’s center patient cohort. Dementia Geriatr Cognitive Disord. 2005;20:198–208.
Davis LL, Weaver M, Habermann B. Differential attrition in a caregiver skill training trial. Res Nurs Health. 2006;29:498–506.
Blanton S, Morris DM, Prettyman MG et al. Lessons learned in participant recruitment and retention: the EXCITE trial. Phys Ther. 2006;86(11):1520–1533.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yadlapalli, J.S.K.B., Martin, I.G. Seeking Predictable Subject Characteristics That Influence Clinical Trial Discontinuation. Ther Innov Regul Sci 46, 313–319 (2012). https://doi.org/10.1177/0092861512440850
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/0092861512440850